Adaptive Biotechnologies Corp (ADPT) Stock Price Today
Aura AI Summary
Key Stats
- $3.85BMarket Cap
- -Volume
- HealthSector
- $24.1852W High
- $10.3352W Low
- -Typical Hold Time
- $3.91BEnterprise Value
- -Div Yield
- -Trading Activity
Track Adaptive Biotechnologies Corp (ADPT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $10.33 and a high of $24.18, highlighting its annual price range. Buy and sell Adaptive Biotechnologies Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Most Recent News
MannyPay Global launches a global payment platform with iMerchant and Adyen, enabling merchants in 70+ countries.
MannyPay Global Inc., chaired by Manny Pacquiao, has launched a global payment facilitator platform in partnership with iMerchant and powered by Adyen. The platform supports merchants across more than 70 countries and 135 currencies with features lik...
Bowhead Specialty Holdings downgraded to Neutral after $1.2B acquisition deal by American Family Mutual Insurance.
Bowhead Specialty Holdings Inc. is being acquired by American Family Mutual Insurance for $1.2 billion in an all-cash deal. Following the announcement, Piper Sandler downgraded Bowhead's stock rating to Neutral due to limited short-term growth potent...
Lantheus downgraded to Hold after $6.7B Curium acquisition deal with conditional payouts.
Lantheus Holdings was downgraded from Buy to Hold by Cowen & Co. following its $6.7 billion acquisition agreement with Curium. Shareholders will receive $102.50 per share in cash, close to the current stock price, limiting upside potential. Additiona...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.